Here are Wall Street's favorite stocks in the sector expected to grow profits the most in 2024
By Philip van Doorn
It may be better for you as an investor to look beyond quarterly earnings season that begins this week
Each earnings reporting season, you can count on a flurry of articles with headlines saying companies "beat" consensus estimates for quarterly profits. But that "success" alone means nothing. A 70% "beat rate" among the S&P 500 is typical. And an earnings beat may be a net loss that was lower than expected. It is as if companies in their guidance and analysts working for brokerage firms underestimate to set up the beats.
The U.S. earnings season will begin on Friday when the largest U.S. banks report their fourth-quarter results. Investors can expect a rough batch of comparisons with year-earlier results, in part because of myriad one-time items that will lower profits.
Maybe it would be better for investors to look ahead to 2024 to see which companies are expected to grow annual profits the most. One way to begin that process is to look at weighted estimates for the 11 sectors of the S&P 500 SPX. All estimates in this article are based on calendar years. About 20% of companies in the S&P 500 have fiscal years that don't match the calendar, but FactSet provides adjusted estimates to match the calendar.
Here are the sectors ranked by how much analysts expect their weighted 2024 earnings-per-share estimates to change from 2023, with the full S&P 500 at the bottom:
Sector or index Expected change in 2024 EPS from 2023 Expected change in 2024 sales from 2023 Price/ weighted consensus 2024 EPS estimate
Healthcare 18.3% 6.2% 18.7
Information Technology 16.7% 9.1% 26.2
Communication Services 16.6% 6.2% 17.4
Consumer Discretionary 12.5% 6.8% 25.5
Industrials 11.9% 5.1% 19.7
Financials 8.5% 5.7% 14.6
Utilities 8.1% 2.8% 16.2
Consumer Staples 5.6% 2.8% 19.4
Materials 3.3% 1.6% 19.2
Real Estate 3.1% 6.5% 18.0
Energy -0.7% 0.5% 11.3
S&P 500 11.6% 5.2% 19.6
Source: FactSet
Five sectors are expected to increase EPS more quickly than the full index this year, with the Healthcare sector topping the list.
A sector screen
For investors eager to jump aboard the sector expected to be the best earnings grower this year, the Health Care Select Sector SPDR ETF XLV provides broad exposure and spreads risk by holding all 64 stocks in the S&P 500 healthcare sector, weighted by market capitalization.
For investors considering individual healthcare stocks, we screened the group of 64 to narrow the list to companies expected to increase EPS at least 10% this year. Then we cut the list further to 21 with majority "buy" or equivalent ratings among analysts polled by FactSet.
Here they are, ranked by implied 12-month upside potential, based on consensus price targets:
Company Ticker Share "buy" ratings Jan. 8 price Cons. price target Implied 12-month upside potential Expected change in 2024 EPS from 2023
Humana Inc. HUM 73% $460.74 $583.21 27% 11%
Elevance Health Inc. ELV 85% $480.05 $566.21 18% 12%
Incyte Corp. INCY 57% $65.82 $75.85 15% 21%
Insulet Corp. PODD 83% $202.43 $231.52 14% 26%
Cigna Group CI 61% $313.63 $354.34 13% 14%
Zoetis Inc. Class A ZTS 84% $196.15 $220.75 13% 11%
UnitedHealth Group Inc. UNH 78% $536.52 $601.87 12% 12%
ResMed Inc. RMD 74% $172.77 $192.80 12% 12%
DexCom Inc. DXCM 88% $129.63 $141.70 9% 20%
West Pharmaceutical Services Inc. WST 55% $351.85 $382.46 9% 10%
GE Healthcare Technologies Inc. GEHC 60% $77.36 $83.88 8% 11%
Boston Scientific Corp. BSX 87% $58.42 $63.16 8% 12%
Stryker Corp. SYK 59% $299.98 $323.96 8% 11%
McKesson Corp. MCK 78% $476.63 $512.47 8% 11%
Merck & Co. Inc. MRK 85% $117.38 $125.03 7% 484%
Edwards Lifesciences Corp. EW 53% $75.67 $79.04 4% 10%
Intuitive Surgical Inc. ISRG 63% $328.86 $340.58 4% 15%
Eli Lilly and Co. LLY 77% $626.03 $645.73 3% 87%
Align Technology Inc. ALGN 75% $273.94 $282.32 3% 11%
Idexx Laboratories Inc. IDXX 62% $543.96 $542.15 0% 12%
Vertex Pharmaceuticals Inc. VRTX 69% $419.12 $417.22 0% 10%
Source: FactSet
If you are considering individual stocks, you should do your own research to form your own opinion about how likely a company is to remain competitive for the next decade, at least. One way to begin that process is by clicking on the tickers.
Click here for Tomi Kilgore's detailed guide to the wealth of information available for free on the MarketWatch quote page.
Don't miss: This ETF's strategy has been working, and the numbers point to continued success
-Philip van Doorn
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-13-24 0658ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits